Such additive effect on chronic p65 activation provided an emerging scenario that E.d promoted CRC through being a potent, chronic trigger for aberrant NF-κB activity potentially for both the innate immunity cells and the gut epithelial cells themselves. The gene discussed is NFKB1; the disease is colorectal carcinoma.